Published online September 1, 2006
PEDIATRICS Vol. 118 No. 3 September 2006, pp. 1056-1064 (doi:10.1542/peds.2006-0195)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheffield, M.
Right arrow Articles by Truog, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheffield, M.
Right arrow Articles by Truog, W. E.
Related Collections
Right arrow Respiratory Tract
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Pulmonary Nitric Oxide Synthases and Nitrotyrosine: Findings During Lung Development and in Chronic Lung Disease of Prematurity

Mark Sheffield, MD, Sherry Mabry, MS, Donald W. Thibeault, MD and William E. Truog, MD

Children's Mercy Hospitals and Clinics, Section of Neonatology, Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri

BACKGROUND. Nitric oxide mediates and modulates pulmonary transition from fetal to postnatal life. NO is synthesized by 3 nitric oxide synthase isoforms. One key pathway of nitric oxide metabolism results in nitrotyrosine, a stable, measurable marker of nitric oxide production.

OBJECTIVE. The purpose of this study was to assess, by semiquantitative immunohistochemistry, nitric oxide synthase isoforms and nitrotyrosine at different airway and vascular tree levels in the lungs of neonates at different gestational ages and to compare results in control groups to those in infants with chronic lung disease.

DESIGN/METHODS. Formalin-fixed, paraffin-embedded, postmortem lung blocks were prepared for immunohistochemistry using antibodies to each nitric oxide synthase isoform and to nitrotyrosine. Blinded observers evaluated the airway and vascular trees for staining intensity (0–3 scale) at 5 levels and 3 levels, respectively. The control population consisted of infants from 22 to 42 weeks' gestation who died in <48 hours. Results were compared with gestation-matched infants with varying severity of chronic lung disease.

RESULTS. In control and chronic lung disease groups, 22 to 42 weeks' gestation, staining for all 3 of the nitric oxide synthase isoforms was found in the airway epithelium from the bronchus to the alveolus or distal-most airspace. The abundance or distribution of nitric oxide synthase-3 staining in the airways did not show significant correlation with gestational age or severity of chronic lung disease. In the vascular tree, intense nitric oxide synthase-3 and moderate nitric oxide synthase-2 staining was found; nitric oxide synthase-1 was not consistently stained. Nitrotyrosine did stain in the pulmonary tree. Compared with controls where nitrotyrosine staining was minimal, regardless of gestation, in infants with chronic lung disease there was more than fourfold increase between severe chronic lung disease (n = 12) and either mild chronic lung disease or control infants (n = 16).

CONCLUSIONS. All 3 of the nitric oxide synthase isoforms and nitrotyrosine are detectable by immunohistochemistry early in lung development. Nitric oxide synthase ontogeny shows no significant changes in abundance or distribution with advancing gestational age nor with chronic lung disease. Nitrotyrosine is significantly increased in severe chronic lung disease.

Key Words: pulmonary nitric oxide synthases • lung development • nitrotyrosine

Abbreviations: NO—nitric oxide • NOS—nitric oxide synthase • CLD—chronic lung disease • INO—inhaled nitric oxide • NOS-2—inducible nitric oxide synthase • NOS-3—endothelial cell nitric oxide synthase • NOS-1—neuronal nitric oxide synthase • 3-NT—3-nitrotyrosine

Accepted Mar 28, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. L. Aschner, H. Zeng, M. R. Kaplowitz, Y. Zhang, J. C. Slaughter, and C. D. Fike
Heat shock protein 90-eNOS interactions mature with postnatal age in the pulmonary circulation of the piglet
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L555 - L564.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Latzin and U. Frey
Environmental exposure in relation to exhaled nitric oxide in newborns: is it all about timing?
Eur. Respir. J., August 1, 2008; 32(2): 252 - 254.
[Full Text] [PDF]